Susquehanna International Group, LLP Immunome Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$11.54 - $22.11 $166,176 - $318,384	14,400 Added 58.3%	39,100 $473,000
Q1 2024 May 07, 2024	SELL	$11.01 - $27.34 $227,907 - $565,938	-20,700 Reduced 45.59%	24,700 $609,000
Q4 2023 Feb 14, 2024	BUY	$7.3 - $10.73 $50,370 - $74,037	6,900 Added 17.92%	45,400 $485,000
Q3 2023 Nov 14, 2023	BUY	$6.17 - $9.16 $172,143 - $255,564	27,900 Added 263.21%	38,500 $321,000
Q2 2023 Aug 11, 2023	BUY	$4.7 - $7.91 $49,820 - $83,846	10,600 New	10,600 $83,000
Q3 2022 Nov 14, 2022	BUY	$3.39 - $6.14 $82,377 - $149,202	24,300 New	24,300 $108,000
Q4 2021 Feb 14, 2022	BUY	$12.96 - $23.44 $168,480 - $304,720	13,000 Added 37.9%	47,300 $613,000
Q3 2021 Nov 15, 2021	BUY	$12.5 - $27.76 $428,750 - $952,168	34,300 New	34,300 $835,000

121

47.1M

322K

1.91M

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $135M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.